Korea Biomedical Review (KBR) is an online English newspaper dedicated to delivering essential Korean healthcare news globally. We offer critical information to professionals, scholars, policymakers, and business individuals with an interest in Korea’s pharmaceutical, biotech, and digital health sectors.
Founded in February 2017, KBR is an integral part of The Korean Doctors’ Weekly (www.docdocdoc.co.kr), a media company established by a network of Korean doctors in 1992. With a distinguished 30-year history in the healthcare media industry, The Korean Doctors’ Weekly stands as the most trusted and influential medical newspaper in its sector. In addition to publishing newspapers and producing over 100 books on healthcare, the company hosts a 30-minute audio program airing seven times a week.
Company Details
- Employees
- 4
- Founded
- -
- Address
- 76-1 Dongmak-Ro, Mapo-Gu, 4th Fl.,korea, Republic Of
- Industry
- Internet News
- NAICS
-
Internet Publishing and Broadcasting and Web Search Portals
- Website
- http://www.koreabiomed.com/
- Keywords
- Advertising, E-Newsletter, Lifescience, Healthcare, Content Marketing, Webinars, Publishing, Medical Devices, Pharmaceutials, biotech, IPO, biosimilars.
- HQ
- Seoul
Korea Biomedical Review Questions
Korea Biomedical Review's website is http://www.koreabiomed.com/
Korea Biomedical Review's LinkedIn profile is https://kr.linkedin.com/company/koreakbr
Korea Biomedical Review has
4 employees.
View email and phone details for 4
employees at Korea Biomedical Review.
Korea Biomedical Review's industry is
Internet News
Korea Biomedical Review's top competitors are
The Bio (더바이오),
Lotte Biologics,
Cha Bio Group｜차바이오그룹,
Samsung Biologics,
Koreabio,
히트뉴스,
Biospectator Inc.,
Daewoong Pharmaceutical,
Gc Biopharma (Gc녹십자),
Celltrion Inc.
Korea Biomedical Review's categories are Internet News
Korea Biomedical Review's founding year is 2017
